Article: Cubist Pharmaceuticals Appoints Sylvie Gregoire, Pharm. D., to Its Board of Directors.

LEXINGTON, Mass. -- Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) today announced the appointment of Sylvie Gregoire, Pharm. D., to its Board of Directors. Dr. Gregoire, who has twenty years of pharmaceutical and biotech industry experience, also serves on the boards of IDM-Pharma, a publicly traded company headquartered in San Diego, CA and Caprion Pharmaceuticals, Inc., a privately-owned biotechnology company in Montreal, Canada

Dr. Gregoire was President and Chief Executive Officer, as well as Executive Member of the Board of Directors, of GlycoFi, Inc., from October of 2004 to August of 2005. Prior to joining GlycoFi, Dr. Gregoire served as a consultant to the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!